Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission
Relph KA., Russell CD., Fairfield CJ., Turtle L., de Silva TI., Siggins MK., Drake TM., Thwaites RS., Abrams S., Moore SC., Hardwick HE., Oosthuyzen W., Harrison EM., Docherty AB., Openshaw PJM., Baillie JK., Semple MG., Ho A., Baillie JK., Semple MG., Openshaw PJM., Carson G., Alex B., Bach B., Barclay WS., Bogaert D., Chand M., Cooke GS., Docherty AB., Dunning J., Filipe ADS., Fletcher T., Green CA., Harrison EM., Hiscox JA., Ho AYW., Horby PW., Ijaz S., Khoo S., Klenerman P., Law A., Lim WS., Mentzer AJ., Merson L., Meynert AM., Noursadeghi M., Moore SC., Palmarini M., Paxton WA., Pollakis G., Price N., Rambaut A., Robertson DL., Russell CD., Sancho-Shimizu V., Scott JT., de Silva T., Sigfrid L., Solomon T., Sriskandan S., Stuart D., Summers C., Tedder RS., Thomson EC., Roger Thompson AA., Thwaites RS., Turtle LCW., Gupta RK., Zambon M., Hardwick H., Donohue C., Lyons R., Griffiths F., Oosthuyzen W., Norman L., Pius R., Drake TM., Fairfield CJ., Knight SR., Mclean KA., Murphy D., Shaw CA., Dalton J., Girvan M., Saviciute E., Roberts S., Harrison J., Marsh L., Connor M., Halpin S., Jackson C., Gamble C., Leeming G., Law A., Wham M., Clohisey S., Hendry R., Scott-Brown J., Greenhalf W., Shaw V., McDonald S., Keating S., Ahmed KA., Armstrong JA., Ashworth M., Asiimwe IG., Bakshi S., Barlow SL., Booth L., Brennan B., Bullock K., Catterall BWA., Clark JJ., Clarke EA., Cole S., Cooper L., Cox H., Davis C., Dincarslan O., Dunn C., Dyer P., Elliott A., Evans A., Finch L., Fisher LWS., Foster T., Garcia-Dorival I., Greenhalf W., Gunning P., Hartley C., Jensen RL., Jones CB., Jones TR., Khandaker S., King K., Kiy RT., Koukorava C., Lake A., Lant S., Latawiec D., Lavelle-Langham L., Lefteri D., Lett L., Livoti LA., Mancini M., McDonald S., McEvoy L., McLauchlan J., Metelmann S., Miah NS., Middleton J., Mitchell J., Moore SC., Murphy EG., Penrice-Randal R., Pilgrim J., Prince T., Reynolds W., Matthew Ridley P., Sales D., Shaw VE., Shears RK., Small B., Subramaniam KS., Szemiel A., Taggart A., Tanianis-Hughes J., Thomas J., Trochu E., van Tonder L., Wilcock E., Eunice Zhang J., Flaherty L., Maziere N., Cass E., Doce Carracedo A., Carlucci N., Holmes A., Massey H., Murphy L., Wrobel N., McCafferty S., Morrice K., MacLean A., Adeniji K., Agranoff D., Agwuh K., Ail D., Aldera EL., Alegria A., Angus B., Ashish A., Atkinson D., Bari S., Barlow G., Barnass S., Barrett N., Bassford C., Basude S., Baxter D., Beadsworth M., Bernatoniene J., Berridge J., Best N., Bothma P., Chadwick D., Brittain-Long R., Bulteel N., Burden T., Burtenshaw A., Caruth V., Chadwick D., Chambler D., Chee N., Child J., Chukkambotla S., Clark T., Collini P., Cosgrove C., Cupitt J., Cutino-Moguel M-T., Dark P., Dawson C., Dervisevic S., Donnison P., Douthwaite S., DuRand I., Dushianthan A., Dyer T., Evans C., Eziefula C., Fegan C., Finn A., Fullerton D., Garg S., Garg S., Garg A., Gkrania-Klotsas E., Godden J., Goldsmith A., Graham C., Hardy E., Hartshorn S., Harvey D., Havalda P., Hawcutt DB., Hobrok M., Hodgson L., Hormis A., Jacobs M., Jain S., Jennings P., Kaliappan A., Kasipandian V., Kegg S., Kelsey M., Kendall J., Kerrison C., Kerslake I., Koch O., Koduri G., Koshy G., Laha S., Laird S., Larkin S., Leiner T., Lillie P., Limb J., Linnett V., Little J., Lyttle M., MacMahon M., MacNaughton E., Mankregod R., Masson H., Matovu E., McCullough K., McEwen R., Meda M., Mills G., Minton J., Mirfenderesky M., Mohandas K., Mok Q., Moon J., Moore E., Morgan P., Morris C., Mortimore K., Moses S., Mpenge M., Mulla R., Murphy M., Nagel M., Nagarajan T., Nelson M., O’Shea MK., Otahal I., Ostermann M., Pais M., Panchatsharam S., Papakonstantinou D., Paraiso H., Patel B., Pattison N., Pepperell J., Peters M., Phull M., Pintus S., Pooni JS., Post F., Price D., Prout R., Rae N., Reschreiter H., Reynolds T., Richardson N., Roberts M., Roberts D., Rose A., Rousseau G., Ryan B., Saluja T., Shah A., Shanmuga P., Sharma A., Shawcross A., Sizer J., Shankar-Hari M., Smith R., Snelson C., Spittle N., Staines N., Stambach T., Stewart R., Subudhi P., Szakmany T., Tatham K., Thomas J., Thompson C., Thompson R., Tridente A., Tupper-Carey D., Twagira M., Ustianowski A., Vallotton N., Vincent-Smith L., Visuvanathan S., Vuylsteke A., Waddy S., Wake R., Walden A., Welters I., Whitehouse T., Whittaker P., Whittington A., Papineni P., Wijesinghe M., Williams M., Wilson L., Cole S., Winchester S., Wiselka M., Wolverson A., Wootton DG., Workman A., Yates B., Young P.
Abstract Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).